Loading...
Establishment Labs Holdings Inc.
ESTA•NASDAQ
Healthcare
Medical - Devices
$42.41
$-0.74(-1.70%)
Establishment Labs Holdings Inc. (ESTA) Financial Performance & Income Statement Overview
Review Establishment Labs Holdings Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.53%
↑ 0.53%
Operating Income Growth
23.13%
↑ 23.13%
Net Income Growth
-7.76%
↓ 7.76%
Operating Cash Flow Growth
33.89%
↑ 33.89%
Operating Margin
-34.13%
↓ 34.13%
Gross Margin
66.35%
↑ 66.35%
Net Profit Margin
-52.34%
↓ 52.34%
ROE
-210.43%
↓ 210.43%
ROIC
-21.98%
↓ 21.98%
Establishment Labs Holdings Inc. (ESTA) Income Statement & Financial Overview
Review Establishment Labs Holdings Inc.'s (ESTA) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $44.51M | $40.23M | $44.12M | $37.17M |
| Cost of Revenue | $14.02M | $14.51M | $15.18M | $12.79M |
| Gross Profit | $30.49M | $25.72M | $28.94M | $24.38M |
| Gross Profit Ratio | $0.68 | $0.64 | $0.66 | $0.66 |
| R&D Expenses | $5.14M | $4.80M | $5.49M | $4.27M |
| SG&A Expenses | $44.02M | $34.05M | $32.79M | $28.94M |
| Operating Expenses | $49.16M | $38.86M | $38.28M | $33.21M |
| Total Costs & Expenses | $63.18M | $53.37M | $53.46M | $46.001M |
| Interest Income | $199000.00 | $234000.00 | $556000.00 | $488000.00 |
| Interest Expense | $5.95M | $5.31M | $5.19M | $4.38M |
| Depreciation & Amortization | $2.39M | $2.19M | $1.58M | $1.41M |
| EBITDA | -$27.60M | -$8.67M | -$9.98M | -$9.97M |
| EBITDA Ratio | -$0.62 | -$0.22 | -$0.18 | -$0.27 |
| Operating Income | -$18.67M | -$13.14M | -$9.34M | -$8.83M |
| Operating Income Ratio | -$0.42 | -$0.33 | -$0.21 | -$0.24 |
| Other Income/Expenses (Net) | -$17.27M | -$3.03M | -$7.41M | -$6.93M |
| Income Before Tax | -$35.94M | -$16.17M | -$16.75M | -$15.76M |
| Income Before Tax Ratio | -$0.81 | -$0.40 | -$0.38 | -$0.42 |
| Income Tax Expense | -$1.41M | $510000.00 | $428000.00 | $438000.00 |
| Net Income | -$34.53M | -$16.68M | -$17.18M | -$16.20M |
| Net Income Ratio | -$0.78 | -$0.41 | -$0.39 | -$0.44 |
| EPS | -$1.19 | -$0.60 | -$0.62 | -$0.58 |
| Diluted EPS | -$1.19 | -$0.60 | -$0.62 | -$0.58 |
| Weighted Avg Shares Outstanding | $28.94M | $27.91M | $27.91M | $27.79M |
| Weighted Avg Shares Outstanding (Diluted) | $28.94M | $27.91M | $27.91M | $27.79M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan